Featured Articles
Trending Articles
Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor
Clinical Trials | 24 May 2024
Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials
Clinical Trials | 23 May 2024
Pfizer Reports Promising Survival Benefits in Vepdegestrant Trial for Breast Cancer
Clinical Trials | 16 May 2024
Oregon & Lantern Pharma's Strategic AI Collaboration to Enhance Cancer Drug
Digital Health | 6 May 2024
Novartis Expands Radioligand Therapy Portfolio with $1B Acquisition of Mariana
ONCOLife | 3 May 2024
FDA Grants Full Approval for Tivdak® to Treat Recurrent or Metastatic Cervical Cancer
FDA & EMA | 1 May 2024
GenFleet Receives FDA Approval for P3 Trial of GFH925 in Colorectal Cancer Treatment
FDA & EMA | 29 April 2024
Flindr Receives €20 Million to Advance Precision Cancer Treatments with RNF31 Inhibitor
Pharma
23 April 2024
FDA Approves Lutathera as First Treatment for Pediatric Neuroendocrine Tumors
FDA & EMA
24 April 2024
FDA Approves New Imaging System to Enhance Tumor Detection in Cancer Surgery
FDA & EMA
21 April 2024
Roche's Blood Test for Alzheimer's Earns FDA Breakthrough Device Designation
FDA & EMA
18 April 2024
Dr. Redkar Unveils the Role of Targeted and Histology-Agnostic Therapies in Cancer
ONCOLife
5 April 2024
P3 Study Shows Obesity Drug Tirzepatide Reduces Sleep Apnea Severity by Up to 63%
Clinical Trials
18 April 2024
Roche's Phase III Study Promises Effective Ocrevus Injection for Multiple Sclerosis
Clinical Trials
17 April 2024
FDA Clears Spinogenix's Phase 2a Trial for Innovative Fragile X Syndrome Treatment
FDA & EMA
15 April 2024